TipRanks
Go Ultimate75% OFF

Clet Niyikiza Insider Profile

4 Followers

Clet Niyikiza, former EVP of Development at Merrimack Pharmaceuticals, holds 141.51K shares in Merrimack Pharmaceuticals (Ticker: MACK). Most recently, Clet Niyikiza Bought 41,507 shares of Merrimack Pharmaceuticals on Feb 06, 2013 for an estimated value of $87.99K.

Clet Niyikiza's Trading History

MACK
Merrimack Pharmaceuticals
Feb 06, 2013―Informative Buy87.99K$2.14M
MACK
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 06, 2013Informative Buy$87.99K41,507$2.12-28.20%
Dec 19, 2012Informative Buy$212.00K100,000$2.12-24.10%

You May Also Like

Clet Niyikiza insider profile FAQ

What is the percentage of profitable transactions made by Clet Niyikiza?
The percentage of profitable transactions made by Clet Niyikiza is 0%.
What is the average return per transaction made by Clet Niyikiza?
The average return per transaction made by Clet Niyikiza is -26.10%.
What stocks does Clet Niyikiza hold?
Clet Niyikiza holds: MACK stocks.
What was Clet Niyikiza’s latest transaction?
Clet Niyikiza’s latest transaction was an Informative Buy of $87.99K.
What was Clet Niyikiza's most profitable transaction?
Clet Niyikiza’s most profitable transaction was an Informative Buy of MACK stock on December 19, 2012. The return on the trade was -24.10%.
What is Clet Niyikiza's role in Merrimack Pharmaceuticals?
Clet Niyikiza's role in Merrimack Pharmaceuticals is EVP of Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.